Physician profile
Randall W Black
NPI 1942268909
$1,567.30
in general payments reported to CMS, 2019-2025
16 companies · $345 in 2025
The $345 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $17.84 · 2021: $125 · 2022: $324 · 2023: $271 · 2024: $362 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $978.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $469.06 | 2021-2025 | Dupixent |
| Genzyme Corporation | $349.88 | 2019-2025 | |
| Glaxosmithkline, LLC. | $218.24 | 2021-2025 | Nucala |
| Stryker Corporation | $111.17 | 2019-2024 | Na |
| Polynovo North America LLC | $82.21 | 2023-2024 | Novosorb Btm |
| Inspire Medical Systems, INC. | $57.88 | 2023-2025 | Inspire |
| Merck Sharp & Dohme LLC | $50.18 | 2021-2023 | |
| Intersect Ent, INC. | $42.23 | 2019 | |
| Sanofi-Aventis U.S. LLC | $38.25 | 2021 | |
| Integra Lifesciences Corporation | $34.63 | 2024 | Codman Isocool Aht, Microfrance, Instruments-Orthopedic |
| Smith+Nephew, INC. | $31.79 | 2024 | Tula |
| Olympus America INC. | $22.30 | 2019 | |
| Phathom Pharmaceuticals, INC. | $18.51 | 2024 | Voquezna |
| Osiris Therapeutics INC. | $14.48 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.43 | 2023 | Seglentis |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.